These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 942485)

  • 1. N-Acetyl, 4-O-methyldopa, a major metabolite of L-4-O-methyldopa in man and rat.
    Mathieu P; Greffe J; Deruaz D; Guilluy R; Gjessing L
    Biochem Pharmacol; 1976 Mar; 25(5):497-500. PubMed ID: 942485
    [No Abstract]   [Full Text] [Related]  

  • 2. The 4-o-methyl metabolites of catecholamines. Homo-iso-vanillic acid in rat urine and brain; urinary iso-vanyl compounds after intraperitoneal administration of dopamine and of dopamine precursors and derivatives.
    Mathieu P; Charvet JC; Greffe J
    Biochem Pharmacol; 1975 Jan; 24(1):43-8. PubMed ID: 1122261
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of a catechol-O-methyl transferase inhibitor, U-0521, with levodopa administration.
    Fahn S; Comi R; Snider SR; Prasad AL
    Biochem Pharmacol; 1979 Apr; 28(7):1221-5. PubMed ID: 444281
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolism of L-3-O-methyldopa, a precursor of dopa in man.
    Kuruma I; Bartholini G; Tissot R; Pletscher A
    Clin Pharmacol Ther; 1971; 12(4):678-82. PubMed ID: 5567811
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urinary excretion of 3,4-dihydroxyphenyl-alanine, 3-O-methyldopa, dopamine and homovanillic acid in man. Effects of an inhibitor of decarboxylase of aromatic amino acids (Benserazide) (author's transl)].
    Geissbühler F; Widmer J
    J Clin Chem Clin Biochem; 1976 Nov; 14(11):543-7. PubMed ID: 1003116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester.
    Vickers S; Duncan CA; Ramjit HG; Dobrinska MR; Dollery CT; Gomez HJ; Leidy HL; Vincek WC
    Drug Metab Dispos; 1984; 12(2):242-6. PubMed ID: 6144491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
    Lloyd KG; Davidson L; Hornykiewicz O
    J Pharmacol Exp Ther; 1975 Dec; 195(3):453-64. PubMed ID: 489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopa, 3-O-methyldopa, and metabolites in urine during oral L-3-O-methyldopa therapy.
    Sharpless NS; Tyce GM; Muenter MD; Dinapoli RP
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 1):770-81. PubMed ID: 4426145
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats.
    Rose S; Jenner P; Marsden CD
    Mov Disord; 1988; 3(2):117-25. PubMed ID: 3221899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-O-methyldopa, a new precursor of dopamine.
    Bartholini G; Kuruma I; Pletscher A
    Nature; 1971 Apr; 230(5295):533-4. PubMed ID: 4927759
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of alpha-methyldopa on the metabolism of dopamine in the striatum of the rat.
    Uretsky NJ
    J Pharmacol Exp Ther; 1974 May; 189(2):359-69. PubMed ID: 4829219
    [No Abstract]   [Full Text] [Related]  

  • 12. 3-O-methyldopa blocks dopa metabolism in rat corpus striatum.
    Reches A; Fahn S
    Ann Neurol; 1982 Sep; 12(3):267-71. PubMed ID: 7137962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two new inhibitors of catechol O-methylation on striatal dopamine metabolism: a microdialysis study in rats.
    Törnwall M; Kaakkola S; Tuomainen P; Kask A; Männistö PT
    Br J Pharmacol; 1994 May; 112(1):13-8. PubMed ID: 7518301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early L-dopa treatment initially retards but later enhances dopamine receptor supersensitivity following unilateral dopamine denervation.
    Carey RJ; Pinheiro-Carrera M; Tomaz C; Huston JP
    Brain Res; 1994 Sep; 658(1-2):145-54. PubMed ID: 7834335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.
    Rivera-Calimlim L
    Br J Pharmacol; 1974 Feb; 50(2):259-63. PubMed ID: 4425764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible inhibition of aromatic-L-amino acid decarboxylase by alpha-difluoromethyl-DOPA and metabolism of the inhibitor.
    Ribéreau-Gayon G; Palfreyman MG; Zraïka M; Wagner J; Jung MJ
    Biochem Pharmacol; 1980 Sep; 29(18):2465-9. PubMed ID: 7426053
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of succinimidoethyl and pivaloyloxyethyl esters as progenitors of methyldopa in man, rhesus monkey, dog, and rat.
    Vickers S; Duncan CA; White SD; Breault GO; Royds RB; de Schepper PJ; Tempero KF
    Drug Metab Dispos; 1978; 6(6):640-6. PubMed ID: 33026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolism of 14 C-labelled -methyldopa in normal and hypertensive human subjects.
    Au WY; Dring LG; Grahame-Smith DG; Isaac P; Williams RT
    Biochem J; 1972 Aug; 129(1):1-10. PubMed ID: 4646774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethylation of 3-O-methyldopa.
    Chalmers JP; Davies DS; Draffan GH; Reid JL; Thorgeirsson SS
    Br J Pharmacol; 1971 Oct; 43(2):455P-456P. PubMed ID: 5158231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.